Inverse psoriasis treated with ustekinumab.
Inverse psoriasis treated with ustekinumab.
复制标题
DOI:
10.1136/bcr-2016-215019
复制
发表时间:
2016-05-24
期刊:
影响因子:
0.9
通讯作者:
Moreira, Ana Isabel
中科院分区:
文献类型:
--
作者:
Campos, Manuel Antonio;Varela, Paulo;Moreira, Ana Isabel
Inverse psoriasis is characterised by the involvement of flexural skin folds. This form of psoriasis has distinct clinical and therapeutic features. This report refers to the case of a 48-year-old Caucasian man who was observed in our department, with a clinically and biopsy proven diagnosis of inverse psoriasis. For 2 years, the patient was treated with different combinations of corticosteroids, vitamin D analogues and methotrexate, with no satisfactory response. Given the lack of a clinical response and comorbidities, latent tuberculosis was excluded, and we started treatment with ustekinumab. We chose this biological agent because the patient was a long-distance truck driver and refused the possibility of autoinjections. The patient underwent three ustekinumab injections, which resulted in significant improvement of pruritus, erythaematous lesions and quality of life.